Baxdrostat and Other Aldosterone Synthase Inhibitors for Uncontrolled Hypertension in CKD

dc.contributor.authorMarieta P. Theodorakopoulou
dc.contributor.authorPantelis Sarafidis
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:56:00Z
dc.date.available2026-03-22T19:56:00Z
dc.date.issued2025
dc.identifier.doi10.1681/asn.0000000978
dc.identifier.urihttps://doi.org/10.1681/asn.0000000978
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/78991
dc.language.isoen
dc.publisherAmerican Society of Nephrology
dc.relation.ispartofJournal of the American Society of Nephrology
dc.sourceAristotle University of Thessaloniki
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectEndocrinology
dc.subjectKidney disease
dc.subjectAldosterone
dc.subjectAldosterone synthase
dc.subjectEnzyme inhibitor
dc.subjectATP synthase
dc.subjectKidney
dc.titleBaxdrostat and Other Aldosterone Synthase Inhibitors for Uncontrolled Hypertension in CKD
dc.typearticle

Files